what does syncom formulations (india) do

Syncom Formulations (India) Limited is a global pharmaceutical company that manufactures and markets a broad range of healthcare products, operating in more than 15 countries worldwide with over 400 products registered.

what products does syncom formulations (india) make

Syncom Formulations (India) produces a wide range of pharmaceutical products, including generics, and has its own manufacturing facility in Pithampur, Madhya Pradesh, focusing on quality and exports.

Syncom Formulations (India) is involved in the manufacturing and exporting of high-quality pharmaceutical products, representing a synergistic approach to healthcare solutions.

what sector is syncom formulations (india) in

Syncom Formulations (India) operates in the pharmaceutical sector, specifically as a generic pharmaceutical player with a global presence.

who owns syncom formulations (india)

Syncom Formulations (India) is a publicly listed company incorporated in 1988, owned by its shareholders, and operates as a non-government entity.

Syncom Formulations (India) Limited (SYNCOMF) Share Price Today — ₹13.6

Syncom Formulations (India) Limited (SYNCOMF) live stock price is ₹13.6 with a change of -4.90% today. Listed on NSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Syncom Formulations (India) Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Syncom Formulations (India) Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

SYNCOMF

NSEBSE

Syncom Formulations (India) Limited

Healthcare· Pharmaceuticals & Biotechnology· INE312C01025· Scrip: 524470

EN हिन्दी ગુજરાતી मराठी

₹13.60

▼ 0.70 (-4.90%)

20/4/2026, 10:29:40 pm

NSE

₹13.60

▼ 0.70

-4.90%

BSE

₹13.66

▲ 0.01

+0.00%

244 trading days · 1Y period

TODAY 

Open14.21

High14.41

Low13.30

Prev Close14.30

Volume94.00Cr

Value₹0.4Cr

L: 13.30H: 14.41

52 WEEK

Low₹10.21

High₹23.49

26% of 52W range

Info

Face Value₹1

Listed2022-11-18

ISININE312C01025

SeriesB

BSE Scrip524470

Key Metrics

1D

+0.07%

1W

-0.29%

1M

+21.37%

3M

+13.49%

6M

-15.70%

Valuation

P/E (TTM)27.06

P/E (Qtr Ann.)24.64

P/Sales2.76

Mkt Cap₹1081 Cr

Growth (QoQ)

Revenue+24.65%

PAT+17.05%

EPS-12.50%

Profitability

EBITDA Margin14.6%

Net Margin10.2%

TTM EBITDA M.14.7%

TTM Net M.10.0%

Dividend

Yield—

Latest DPS—

Payout Ratio—

Growth—

TTM Revenue

₹392 Cr

TTM EBITDA

₹57 Cr

TTM PAT

₹39 Cr

TTM EPS

₹0.51

Rev/Share

₹4.2

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	128 Cr	114 Cr	19 Cr	17 Cr	13 Cr	₹0.14
2024-09-30	102 Cr	92 Cr	16 Cr	15 Cr	11 Cr	₹0.16
2024-06-30	87 Cr	78 Cr	11 Cr	10 Cr	8 Cr	₹0.11
2024-03-31	75 Cr	68 Cr	11 Cr	10 Cr	7 Cr	₹0.10
2023-12-31	65 Cr	60 Cr	11 Cr	9 Cr	7 Cr	₹0.09
2023-09-30	64 Cr	59 Cr	9 Cr	8 Cr	7 Cr	₹0.08
2023-06-30	60 Cr	56 Cr	7 Cr	6 Cr	4 Cr	₹0.07
2023-03-31	61 Cr	57 Cr	11 Cr	10 Cr	8 Cr	₹0.10

Shareholding Pattern

CURRENT — 2026-03-31

Promoter50.6%

FII0.2%

Public49.4%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2024-09-23	Other	Annual General Meeting
2023-09-18	Other	Annual General Meeting

Price History

Date	Open	High	Low	Close	Volume
2026-04-30	13.79	13.94	13.52	13.74	10.60L
2026-04-29	13.91	14.14	13.70	13.79	14.03L
2026-04-28	13.80	14.14	13.60	13.91	13.86L
2026-04-27	13.50	14.14	13.50	14.02	16.41L
2026-04-24	13.94	13.95	13.40	13.47	13.14L
2026-04-23	13.78	14.15	13.70	13.84	15.23L
2026-04-22	13.65	13.94	13.60	13.85	13.35L
2026-04-21	13.67	13.88	13.56	13.65	12.77L
2026-04-20	14.21	14.41	13.30	13.59	32.06L
2026-04-17	13.95	14.43	13.81	14.30	28.18L
2026-04-16	13.80	14.19	13.71	13.95	21.76L
2026-04-15	13.60	13.95	13.58	13.80	21.27L
2026-04-13	13.39	13.55	12.89	13.37	26.68L
2026-04-10	13.22	13.93	13.16	13.56	31.51L
2026-04-09	13.36	13.38	12.82	12.99	18.26L
2026-04-08	13.53	13.53	12.67	13.11	37.99L
2026-04-07	11.85	12.42	11.66	12.25	26.54L
2026-04-02	11.00	11.50	10.72	11.30	19.88L
2026-04-01	10.70	11.32	10.47	11.17	23.53L
2026-03-27	11.55	11.55	10.90	10.94	30.14L
2026-03-25	11.35	11.79	11.35	11.56	15.37L
2026-03-24	11.85	11.85	11.20	11.37	21.37L
2026-03-20	11.71	11.99	11.64	11.78	17.84L
2026-03-19	11.71	11.96	11.66	11.70	12.50L
2026-03-18	11.72	12.12	11.63	11.97	15.65L
2026-03-17	12.20	12.20	11.47	11.56	32.00L
2026-03-16	12.06	12.35	11.70	11.82	18.67L
2026-03-13	12.40	12.40	11.97	12.06	16.59L
2026-03-12	12.41	12.59	12.08	12.40	10.78L
2026-03-11	12.42	12.60	12.31	12.40	16.21L

Frequently Asked Questions

About

Syncom Formulations (India) Limited, a global pharmaceutical company established in 1995, designs, manufactures, and markets a diverse range of healthcare products. Their portfolio includes APIs, intermediates, and fine chemicals serving both domestic and international markets. Notably, the company has maintained a significant market position with a capitalization exceeding ₹1,287 crores.

BOARD OF DIRECTORS

Ritesh Kumar Lunkad

Director

Prachi Jain

SYNCOM